Advertisement
Advertisement
U.S. markets close in 5 hours 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.01100.0000 (0.00%)
As of 01:25PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0110
Open0.0110
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0110 - 0.0110
52 Week Range0.0110 - 0.1803
Volume1,300
Avg. Volume36,106
Market Cap1.827M
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-0.0060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NRXCF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NEUTRISCI INTL INC
    ORLY: Lowering target price to $889.00O'REILLY AUTOMOTIVE INC has an Investment Rating of HOLD; a target price of $889.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • CNW Group

    NEUTRISCI SHIPS ORDER TO TABLETZ DISTRIBUTION PARTNER

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has shipped an additional order to Tabletz LLC.

  • CNW Group

    NEUTRISCI PROVIDES UPDATE AND PARTNER PROGRESS

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTC PINK: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide the following update.

  • CNW Group

    NEUTRISCI ANNOUNCES VOLUNTARY DELISTING FROM OTCQB

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, announces that, it in order to direct capital to other activities, will voluntarily delist its common shares from trading on the OTCQB. The delisting will be effective prior to the opening of the markets on February 1, 2022.

Advertisement
Advertisement